SK3 Group Distribution of SKTO Products Growing
August 27 2013 - 9:41AM
Marketwired
SK3 Group, Inc. (PINKSHEETS: SKTO) ("the Company") has announced
that its licensed products are seeing wide distribution across
California. As of July 2013, the Company's recipes and brands can
be found in over 58 medical cannabis dispensaries throughout
California. Some of these products include Yak Whole Plant Extract
Capsules in Indica, Sativa and High CBD, which contain the
non-psychoactive cannabinoid cannabidiol, Yak Haute Chocolate
instant chocolate drink, Yak Mocha-Juana instant chocolate &
coffee drink, Yak Greenie Whole Plant Extract Cookie, Yeti Premium
Preroll for powerful pain relief which contains high-quality
cannabis flowers impregnated with potent Red Diamond oil, and
Organakoil whole plant extract which is used for the "Simpson
Treatment." The Company is undertaking strategies to ensure that
the number of retail points selling these licensed products
continues to grow aggressively in the coming months.
A. Mayer, President SK3 Group, said, " Mass distribution in the
States that are now selling medical cannabis is the key to the
growth of the company and ultimately the revenue and we feel we are
making great strides toward that end."
About SK3 Group, Inc. SK3 is a healthcare
logistics and fulfillment consultancy focused on the delivery of
alternative care and medicine. With seasoned management,
breakthrough technology and best practices, SK3 brings
standardization and transparency to this rapidly growing segment of
the alternative care field.
Safe Harbor Statement Safe Harbor
Statement under the Private Securities Litigation Reform Act of
1995: This news release may contain forward-looking information
within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended, including statements that include the words "believes",
"expects", "anticipates" or similar expressions. Such
forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results,
performance or achievements to differ materially from those
expressed or implied by such forward-looking statements. This news
release speaks as of the date first set forth above and no
responsibility or obligation may be assumed or exists to update the
information included herein for events occurring after the date
hereof.
Investor Relations Contact joanne@rubiconcapitaladvisors.com
TEL: 855-868-7577 (Dial 1 for direct IR)
www.rubiconcapitaladvisors.com
SK3 (CE) (USOTC:SKTO)
Historical Stock Chart
From Aug 2024 to Sep 2024
SK3 (CE) (USOTC:SKTO)
Historical Stock Chart
From Sep 2023 to Sep 2024